Ataractic treatment in psychiatry and general medicine. Neuroleptics and thymoleptics. 3.1 Neuroleptics
Hertrich, O.
Fortschritte der Medizin 101(40): 1823; 1826-1827
1983
ISSN/ISBN: 0015-8178 PMID: 6139328 Document Number: 200614
Document emailed within 1 workday
Related Documents
Hertrich, O. 1983: Ataractic treatment in psychiatry and general medicine. Overview of preparations, 2 Fortschritte der Medizin 101(21): 992-994Hertrich, O. 1983: Ataractic treatment in psychiatry and general medicine. Survey of drugs, 4 Fortschritte der Medizin 101(25): 1183-1184; 1186
Crane, G.E. 1973: Clinical psychopharmacology in its 20th year. Late, unanticipated effects of neuroleptics may limit their use in psychiatry Science 181(4095): 124-128
Fritze, J.; Schmauss, M. 2003: Alteration of the guidelines on pharmaceuticals of the National Committee of Physicians and Health Insurers with regard to atypical neuroleptics. Statement of the German Scoiety of Psychiatry, Psychotherapy and Neurology (DGPPN) Der Nervenarzt 74(1): 97-99
Wiesel, F.A.; Thelander, S. 1998: Science, not opinions, should direct the therapy with neuroleptics. Uncontrolled observations are not evidence-based medicine Lakartidningen 95(25): 2908-2909
Guensberger, E.; Molcan, J. 1978: The aim of neuroleptics in the context of the treatment of depression Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 19(C): 121-124
Puzyński, S.; Jakubik, A.; Kalinowski, A. 1973: Cognition disorders in the course of treatment with neuroleptics Psychiatria Polska 7(4): 453-459
Zaitsev, V.P. 1975: Differentiated use of neuroleptics in treatment of myocardial infarct Klinicheskaia Meditsina 53(7): 61-65
Rust, M. 1983: Use of tiapride in persistent tardive dyskinesia following treatment with neuroleptics Münchener Medizinische Wochenschrift 125(21): 461-462
Marsálek, M. 1989: Tardive dyskinesia after low doses of neuroleptics and attempts at treatment Ceskoslovenska Psychiatrie 85(2): 100-105
Epperly, T.D.; McGlaughlin, V.G.; Leo, K.U. 1990: A hazardous side effect of neuroleptics: diagnosis and treatment Geriatrics 45(8): 58-62
Masi, G. 1997: Atypical neuroleptics in the treatment of early onset schizophrenia Panminerva Medica 39(3): 215-221
Paolucci, S.; Buttinelli, C.; Fiume, S.; Ciani, S.; Lenzi, G.L. 1984: Treatment of Gilles de la Tourette syndrome with depot neuroleptics Acta Neurologica 6(3): 222-224
Waehrens, J. 1982: Convulsions during simultaneous treatment with neuroleptics and antidepressive agents Ugeskrift for Laeger 144(2): 106-108
Chouinard, G.; Bradwejn, J.; Annable, L.; Jones, B.D.; Ross-Chouinard, A. 1984: Withdrawal symptoms after long-term treatment with low-potency neuroleptics Journal of Clinical Psychiatry 45(12): 500-502
Tverdova, E.B. 1976: An adverse glycemic effect in patients as a result of treatment with neuroleptics Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 76(3): 450-452
Geronimi-Ferret, D.; Lesay, M.; Barges-Bertocchio, M.H.; Cornet-Bonnefont, M.; Robert, H. 1997: Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics L'Encephale 23(Special Issue 4): 24-31
Strömstedt, A.; Bergmark, T. 1998: Treatment with neuroleptics--inadequate documentation--in spite of evidence-based experience Lakartidningen 95(28-29): 3159
Biazzi, A.; Fregnan, G.B. 1980: Behavioral, anti-dopaminergic, and prohypnotic effects of neuroleptics during and after prolonged treatment Advances in Biochemical Psychopharmacology 24: 351-357
Dencker, S.J. 1979: Treatment with high doses of neuroleptics in the acute phase of mental diseases Acta Psiquiatrica y Psicologica de America Latina 25(2): 157-160